Login Create Account
 
Power Your Document

Disease and Molecular Basis


# 54566
Disease and Molecular Basis
A look at the molecular basis of cystic fibrosis and muscular dystrophy.
1,232 words (approx. 4.9 pages) | 5 sources | MLA | 2000 United Kingdom


Paper Summary:

This paper examines how there are two main categories of disease for which therapies are currently being investigated at the molecular level. These two categories of disease are genetic and infectious. It discusses cystic fibrosis and muscular dystrophy at the molecular level and looks at possible gene therapy treatments.

From the Paper:

"Therapies for muscular dystrophies are at the moment only for symptomatic treatment, but advances for curing them are being researched. A pharmacological therapy addresses the pathophysiological changes that lead to muscle cell death. Transplantation therapy involves the transfer of myoblasts from an unaffected donor into the muscle of an affected patient. The myoblasts fuse and become part of the patient's own muscle tissue. Gene therapy uses retroviral, adenoviral and herpes vectors to transfer the correct functional DMD gene into patients. One problem with retrovirus is that they are not big enough to carry the 11kb gene, so it has been found that you can cut out some of the coding region to reduce its size, but without affecting its function."

Cite this paper

APA Citation:

Disease and Molecular Basis (2012, January 15). Retrieved February 12, 2012, from http://www.academon.co.uk/Essay-Disease-and-Molecular-Basis/54566

MLA Citation:

"Disease and Molecular Basis" 15 January 2012. Web. 12 Feb. 2012. <http://www.academon.co.uk/Essay-Disease-and-Molecular-Basis/54566>




ATTENTION:

Your browser does not have cookies enabled.

Our shopping cart will not function properly.
Downloadable version: £ 15.95
ADD TO CART »
You will be able to download, read and edit this file once you buy this document
Shopping Cart
Currency:
AcaDemon.com is that one place
Published by:

GB
Publisher Since:
Dec 26, 2004
I completed a BSc in Biomedical Science from Kings College - University of London and then moved to the University of Manchester to complete a PhD in developmental genetics.
Seller Assistance
Share Our Success